Emerging Technology: Page 3

Electronic DNA nanoballs detection enables fast, accurate, cheap pathogen detection

By Nick Paul Taylor

Electronic detection of DNA nanoballs could enable fast, accurate, and cheap identification of pathogens, according to a paper published in Science Advances.

September 18, 2023

Experts raise concerns about Quest Diagnostics’ consumer-initiated Alzheimer’s test

By Nick Paul Taylor

Experts have raised concerns about Quest Diagnostics’ $399 consumer-initiated Alzheimer’s disease test, telling 360Dx that it is unclear whether the product is accurate enough to support its use.

September 15, 2023

NIH awarding $50.3M to establish multiomics consortium

By LabPulse.com staff writers

The U.S. National Institutes of Health (NIH) announced that it will award $50.3 million over five years to establish a multiomics research consortium.

September 14, 2023

Researchers link changes in lipids to human health, disease, and aging

By Nick Paul Taylor

Researchers have tracked changes to lipids during respiratory viral infection, insulin resistance, and aging, suggesting that the fats may play a role in immune homoeostasis and inflammation regulation.

September 13, 2023

Navigate BioPharma, Becton Dickinson collaborate on CDx solutions

By LabPulse.com staff writers

Navigate BioPharma and Becton Dickinson have formed a strategic collaboration to use flow cytometry to develop and commercialize companion diagnostics (CDx) and clinical decision-making solutions.

September 11, 2023

Proteomics study finds plasma proteins linked with type 2 diabetes, diabetic complications

By Matt Limb

An analysis of plasma proteins found to be linked with type 2 diabetes and diabetic complications may help develop therapeutic targets, researchers write in an article published in Cell Reports Medicine.

September 8, 2023

RNA exporters enable nondestructive cell monitoring, delivery of therapeutics

By Nick Paul Taylor

RNA exporters could enable the nondestructive monitoring of cells over time and the targeted delivery of mRNA therapeutics, according to a paper published recently in Cell.

September 5, 2023

C2N Diagnostics rolls out second-generation Alzheimer's disease biomarker test

By Matt Limb

C₂N Diagnostics has unveiled its “next generation” blood biomarker test to evaluate patients with signs and symptoms of Alzheimer’s disease (AD) and other causes of cognitive decline.

August 29, 2023

Raman spectroscopy slashes time to detect pathogens bound to magnetic beads

By Nick Paul Taylor

Raman spectroscopy can accelerate the detection of pathogens bound to microscopic magnetic beads, according to a paper that will be published in the Journal of Raman Spectroscopy.

August 28, 2023

BigOmics outlines expansion, omics pipeline

By Matt Limb

BigOmic’s plan includes providing a more complete pipeline for end-to-end analysis of transcriptomics and proteomics data, according to an interview with GenomeWeb.

August 28, 2023

Amoy Diagnostics, AstraZeneca partner on CDx for lung cancer therapy

By LabPulse.com staff writers

This agreement is the latest in ongoing collaborations to develop and commercialize AmoyDx assays for companion diagnostic use with AstraZeneca's prostate, breast, and ovarian cancer therapies.

August 16, 2023

Foundation Medicine wins FDA approval for companion diagnostic to prostate cancer treatment

By Nick Paul Taylor

FoundationOne CDx analyzes more than 300 cancer-related genes for genomic alterations. The ability of the product to test for alterations and select gene rearrangements and genomic signatures has led to its approval as a CDx for multiple products.

August 16, 2023

Previous Page

Page 3 of 51

Next Page